Net Element (NASDAQ: NETE), in a series of three 8K SEC filings from January 19, 2017, through February 8, 2017 (www.netelement.com/en/ir), has presented to Esousa Holdings, LLC purchase notices aggregating $1.35 million for 1,578,877 shares of its common stock at a price per share ranging from $0.83 to $0.861. Net Element is a technology provider […]

Attendees at the Conference on Retroviruses and Opportunistic Infections (February 13-16) at the Washington State Convention Center in Seattle received a two-year update on CytoDyn’s PRO 140 as a single-agent maintenance therapy for HIV-1 infection. The poster presentation was from Dr. Kush Dhody, Senior Director, Clinical Operations at Amarex Clinical Research, on behalf of CytoDyn […]

A SeeThruEquity report released in February revealed that ChineseInvestors.com, Inc. (OTCQB: CIIX), a specialized investment services company targeting primarily the Chinese-speaking population in the U.S., has made several investments in the global cannabis industry, increasing its growth potential. Still in the early stages of market penetration, the company cited significant potential in its legal cannabis […]

ORHub, Inc. (OTC: ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications […]

Despite a total of 28 states having now legalized marijuana in some form, the U.S Drug Enforcement Administration still classifies cannabis as a Schedule 1 substance, alongside heroin and LSD. With this mind, it has been hard for the banking industry to support legal marijuana businesses. Because such businesses have fewer options in opening bank […]

Perhaps no segment of the travel industry has changed so much over the last few years as lodging and accommodation. Spurred by an initial decline of the global travel market a few years ago but given new life by a new generation of travelers who prefer a different kind of tourism with more personal experiences […]

SeeThruEquity initiated coverage of Moxian, Inc. (NASDAQ: MOXC) on February 8, 2017, projecting that the China-based company will achieve annual revenues of more than $40 million by FY2019 alongside EBITDA of $17.456 million. The investment research firm set a price target of $4.50 for the company’s stock (http://nnw.fm/Kb4Rn). Moxian is focused on the $48 billion […]

According to a just-published article by Royal Lepage (http://dtn.fm/Q6oZR), Canada’s leading real estate services provider, there has been a verified surge of American interest in Canadian real estate following the recent presidential election. The company reported an increase in searches into the Canadian real estate market from across the United States. Although the United States […]

The upcoming Conference On Retroviruses And Opportunistic Infections, to be held at the Washington State Convention Center in Seattle from February 13-16, 2017, is billed to feature a heavyweight clash between GlaxoSmithKline (NYSE: GSK) and Gilead Sciences (NASDAQ: GILD) for the treatment of HIV patients (http://nnw.fm/05mzG). Gilead is expected to present data from mid-stage Phase […]

Leading independent equity research firm SeeThruEquity on February 8, 2017, announced that it has initiated coverage of China’s Moxian, Inc. (NASDAQ: MOXC), with a price target of $4.50 over the next 12 months, according to a press release (http://nnw.fm/Myy0B) from the equity firm. Based in Shenzhen, China, Moxian has quickly developed into one of the […]